Evidence map›Paper›PMID 32936480›Full record

ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2021

A novel engineered purified exosome product patch for tendon healing: An explant in an ex vivo model.

Guidong Shi, Yicun Wang, Zhanwen Wang, Andrew R Thoreson, Daniel S Jacobson, Peter C Amadio, Atta Behfar, Steven L Moran, Chunfeng Zhao

Open access · greenAbstract read
In one paragraph

Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Extracellular Vesicles as Therapeutic Resources in the Clinical Environment.International journal of molecular sciences · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 3 countries.

Guidong ShiDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-1238-6575
Yicun WangDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Zhanwen WangDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Andrew R ThoresonDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Daniel S JacobsonDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Peter C AmadioDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Atta BehfarVan Cleve Cardiac Regenerative Medicine Program, Department of Cardiovascular Diseases, Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Steven L MoranDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Chunfeng ZhaoDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-8737-4587
Mayo Clinic · US

Funding

Engineering Tendon Grafts for Better OutcomesR01AR057745 · NIAMS · MAYO CLINIC ROCHESTER · PI ZHAO, CHUNFENG · 2010 to 2018
$3.5M
Flexor tendon intrinsic healing and intervention strategy developmentR01AR076339 · NIAMS · MAYO CLINIC ROCHESTER · PI ZHAO, CHUNFENG · 2021 to 2025
$2.5M
NIAMS NIH HHS R01 AR057745NIAMS NIH HHS R01 AR076339
6 · The paper itself

Abstract

Reducing tendon failure after repair remains a challenge due to its poor intrinsic healing ability. The purpose of this study is to investigate the effect of a novel tissue-engineered purified exosome product (PEP) patch on tendon healing in a canine ex vivo model. Lacerated flexor digitorum profundus (FDP) tendons from three canines' paws underwent simulated repair with Tisseel patch alone or biopotentiated with PEP. For the ex vivo model, FDP tendons were randomly divided into three groups: FDP tendon repair alone group (Control), Tisseel patch alone group, and the Tisseel plus PEP (TEPEP) patch group. Following 4 weeks of tissue culture, the failure load, stiffness, histology, and gene expression of the healing tendon were evaluated. Transmission electron microscopy revealed that in exosomes of PEP the diameters ranged from 93.70 to 124.65 nm, and the patch release test showed this TEPEP patch could stably release the extracellular vesicle over 2 weeks. The failure strength of the tendon in the TEPEP patch group was significantly higher than that of the Control group and Tisseel alone group. The results of histology showed that the TEPEP patch group had the smallest healing gap and the largest number of fibroblasts on the surface of the injured tendon. Quantitative reverse transcription polymerase chain reaction showed that TEPEP patch increased the expression of collagen type III, matrix metallopeptidase 2 (MMP2), MMP3, MMP14, and reduced the expression of transforming growth factor β1, interleukin 6. This study shows that the TEPEP patch could promote tendon repair by reducing gap formation and inflammatory response, increasing the activity of endogenous cells, and formation of type III collagen.

Indexed as

ExosomesTendon InjuriesAnimalsDogsFibrin Tissue AdhesiveFibroblastsTendonsFibrin Tissue Adhesivefibrin sealantflexor digitorum profundus tendonpurified exosome productstendon healing

Identifiers

PMID32936480
PMCPMC9235100
OpenAlexW3087762892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.